Drug History: WELLBUTRIN

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	WELLBUTRIN
FDA Application No:	(NDA) 018644
Active Ingredient(s):	BUPROPION HYDROCHLORIDE
Company:	GLAXOSMITHKLINE

Label History

View the label approved on August 3, 2007 for WELLBUTRIN, (NDA) 018644

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
8/2/2007	036	Labeling Revision	Letter Label
1/29/2007	035	Labeling Revision	Letter
7/3/2006	034	Labeling Revision	Letter Label
7/3/2006	033	Labeling Revision	Letter Label
2/28/2006	031	Labeling Revision	Letter
1/12/2005	030	Labeling Revision	Letter Label
5/27/2004	028	Labeling Revision	Letter Review
10/22/2002	026	Labeling Revision	Letter
2/13/2002	025	Manufacturing Change or Addition	Letter
10/2/2002	024	Labeling Revision	Letter
6/20/2002	023	Labeling Revision	Letter
6/20/2002	022	Labeling Revision	Letter
4/10/2000	021	Labeling Revision
4/10/2000	020	Labeling Revision
4/10/2000	019	Labeling Revision
4/10/2000	018	Labeling Revision
4/10/2000	017	Labeling Revision
4/10/2000	016	Labeling Revision
4/10/2000	015	Labeling Revision
4/10/2000	014	Labeling Revision
10/31/1996	013	Control Supplement	Review
11/27/1995	012	Labeling Revision	Review
11/27/1995	010	Labeling Revision	Review
6/24/1991	008	Labeling Revision
3/23/1994	007	Package Change
3/23/1994	006	Control Supplement
3/23/1994	005	Formulation Revision
6/24/1991	004	Package Change
5/30/1989	003	Control Supplement
2/11/1986	002	Labeling Revision
2/11/1986	001	Labeling Revision
12/30/1985	000	Approval	Other Important Information from FDA

There are no Therapeutic Equivalents